AU2012900286A0 - "Methods of treatment or prophylaxis" - Google Patents
"Methods of treatment or prophylaxis"Info
- Publication number
- AU2012900286A0 AU2012900286A0 AU2012900286A AU2012900286A AU2012900286A0 AU 2012900286 A0 AU2012900286 A0 AU 2012900286A0 AU 2012900286 A AU2012900286 A AU 2012900286A AU 2012900286 A AU2012900286 A AU 2012900286A AU 2012900286 A0 AU2012900286 A0 AU 2012900286A0
- Authority
- AU
- Australia
- Prior art keywords
- prophylaxis
- treatment
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000000069 prophylaxis Effects 0.000 title 1
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT137414462T PT2807153T (en) | 2012-01-25 | 2013-01-25 | Heterocyclic compounds and methods for their use |
PCT/AU2013/000061 WO2013110134A1 (en) | 2012-01-25 | 2013-01-25 | Heterocyclic compounds and methods for their use |
ES13741446T ES2798289T3 (en) | 2012-01-25 | 2013-01-25 | Heterocyclic compounds and methods for their use |
NZ627560A NZ627560A (en) | 2012-01-25 | 2013-01-25 | Heterocyclic piperazine compounds and methods for their use |
PL13741446T PL2807153T3 (en) | 2012-01-25 | 2013-01-25 | Heterocyclic compounds and methods for their use |
US14/373,355 US20150011565A1 (en) | 2012-01-25 | 2013-01-25 | Heterocyclic Compounds and Methods For Their Use |
AU2013202973A AU2013202973C9 (en) | 2012-01-25 | 2013-01-25 | Heterocyclic compounds and methods for their use |
JP2014553581A JP6258867B2 (en) | 2012-01-25 | 2013-01-25 | Heterocyclic compounds and methods of use thereof |
CN201380016259.9A CN104470903B (en) | 2012-01-25 | 2013-01-25 | Heterocyclic compounds and methods for their use |
EP13741446.2A EP2807153B1 (en) | 2012-01-25 | 2013-01-25 | Heterocyclic compounds and methods for their use |
CA2861231A CA2861231C (en) | 2012-01-25 | 2013-01-25 | Substituted 1-acyl-piperazine and 1-acyl-perhydro-1,4-diazepine compounds and their use as angiotensin ii type 2 receptor antagonists |
ZA2014/05255A ZA201405255B (en) | 2012-01-25 | 2014-07-17 | Heterocyclic compounds and methods for their use |
HK15102125.7A HK1201533A1 (en) | 2012-01-25 | 2015-03-03 | Heterocyclic compounds and methods for their use |
US15/149,641 US9708275B2 (en) | 2012-01-25 | 2016-05-09 | Heterocyclic compounds and methods for their use |
JP2017205744A JP2018076297A (en) | 2012-01-25 | 2017-10-25 | Heterocyclic compounds and methods for their use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2012900286A0 true AU2012900286A0 (en) | 2012-02-16 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUE041553T2 (en) | Methods and compositions for the treatment of monogenic diseases | |
EP2621499A4 (en) | Methods for the treatment of allergic diseases | |
GB2511713B (en) | Compositions for the treatment of bone fragility | |
EP3038610A4 (en) | Compositions and methods for the treatment of presbyopia | |
EP2736528A4 (en) | Compositions and methods for the treatment of hiv | |
HK1201042A1 (en) | Compositions for the treatment of dry eye | |
EP3049070A4 (en) | Compositions and methods for treatment and prophylaxis of gastrointestinal diseases | |
EP2967049A4 (en) | Methods, compounds, and compositions for the treatment of angiotensin-related diseases | |
EP2654745A4 (en) | Composition for the treatment of skin conditions | |
GB201506561D0 (en) | Treatment of amblyopia | |
HUE063599T2 (en) | Methods of treatment or reduction of edematous-fibrosclerotic panniculopathy | |
EP2814491A4 (en) | Formulations and methods for the treatment or prophylaxis of pre-mci and/or pre-alzheimer's conditions | |
AP2014007905A0 (en) | Novel compounds for the treatment of dyslipidemia and related diseases | |
ZA201408062B (en) | Compositions and methods for the treatment of multiple sclerosis | |
EP3082427A4 (en) | Compositions and methods for treatment of glaucoma | |
HK1216721A1 (en) | Uses and methods for the treatment of liver diseases or conditions | |
EP3082845A4 (en) | Methods and compositions for treatment of peripheral neuropathies | |
HK1212619A1 (en) | Method of treatment or prophylaxis of infections of the eye | |
EP3068431A4 (en) | Methods and compositions for the treatment of hcmv | |
ZA201408065B (en) | Compositions and methods for the treatment of diabetes | |
EP2994156A4 (en) | Compounds, compositions and methods for the treatment of diseases through inhibiting tgf- activity | |
IL234796B (en) | Compounds for the treatment of ischemia-reperfusion-related diseases | |
AU2012900286A0 (en) | "Methods of treatment or prophylaxis" | |
AU2012900285A0 (en) | Methods of treatment or prophylaxis | |
AU2012900057A0 (en) | Methods of treatment or prophylaxis |